SOLU-MEDROL® Principal Display Panel (methylprednisolone sodium succinate)

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

PRINCIPAL DISPLAY PANEL - 500 mg Vial Label

NDC 0009-0758-01

Multi-dose vial.
Discard unused portion.

Solu-Medrol®
(methylprednisolone sodium
succinate for injection, USP)

500 mg* per vial

This Package Does Not Contain Diluent.
Recommended Diluent (Bacteriostatic Water
for Injection) Contains Benzyl Alcohol as a
Preservative.

Rx only

PRINCIPAL DISPLAY PANEL - 500 mg Vial Label

PRINCIPAL DISPLAY PANEL - 500 mg Vial Carton

NDC 0009-0758-01

1 Vial
Multi-dose vial.
Discard unused portion.

Solu-Medrol®
(methylprednisolone
sodium succinate
for injection, USP)

500 mg*
per vial

For Intramuscular or
Intravenous Use Only

This Package Does Not Contain
Diluent. The Recommended
Diluent (Bacteriostatic Water
for Injection) Contains Benzyl
Alcohol as a Preservative.

Rx only

Pfizer Injectables

PRINCIPAL DISPLAY PANEL - 500 mg Vial Carton

PRINCIPAL DISPLAY PANEL - 1 gram Vial Label

NDC 0009-0698-01

Multi-dose vial.
Discard unused portion.

Solu-Medrol®
(methylprednisolone sodium
succinate for injection, USP)

1 gram* per vial

For Intramuscular or
Intravenous Use Only

This Package Does Not Contain Diluent.
Recommended Diluent (Bacteriostatic
Water for Injection) Contains Benzyl
Alcohol as a Preservative.

Rx only

PRINCIPAL DISPLAY PANEL - 1 gram Vial Label

PRINCIPAL DISPLAY PANEL - 1 gram Vial Carton

NDC 0009-0698-01

1 Vial
Multi-dose vial.
Discard unused portion.

Solu-Medrol®
(methylprednisolone
sodium succinate
for injection, USP)

1 gram*
per vial

For Intramuscular or
Intravenous Use Only

This Package Does Not Contain
Diluent. The Recommended
Diluent (Bacteriostatic Water
for Injection) Contains Benzyl
Alcohol as a Preservative.

Rx only

Pfizer Injectables

PRINCIPAL DISPLAY PANEL - 1 gram Vial Carton

PRINCIPAL DISPLAY PANEL - 2 gram Vial Label

NDC 0009-0796-01

Single use vial.
Discard unused portion.

Solu-Medrol®
(methylprednisolone sodium
succinate for injection, USP)

2 grams* per vial

For Intramuscular or
Intravenous Use Only

The Enclosed Packaged Diluent
(Bacteriostatic Water for Injection)
Contains Benzyl Alcohol as a
Preservative.

Rx only

PRINCIPAL DISPLAY PANEL - 2 gram Vial Label

PRINCIPAL DISPLAY PANEL - 2 gram Vial Carton

NDC 0009-0796-01

Single use vial.
Discard unused portion.

Solu-Medrol®
(methylprednisolone sodium
succinate for injection, USP)

2 grams* per vial

For Intramuscular or Intravenous Use Only

The Enclosed Packaged Diluent (Bacteriostatic Water for Injection)
Contains Benzyl Alcohol as a Preservative.

Pfizer Injectables
Rx only

PRINCIPAL DISPLAY PANEL - 2 gram Vial Carton

PRINCIPAL DISPLAY PANEL - 40 mg Vial Label

NDC 0009-0039-30

1 mL Act-O-Vial®

Solu-Medrol®
(methylprednisolone sodium
succinate for injection, USP)

40 mg* per vial

Preservative-Free
Rx only

PRINCIPAL DISPLAY PANEL - 40 mg Vial Label

PRINCIPAL DISPLAY PANEL - 40 mg Vial Carton

NDC 0009-0039-28
Contains 25 of NDC 0009-0039-30

Single-Dose Vial.
Discard unused portion.
25–1 mL Act-O-Vial® Systems

Solu-Medrol®
(methylprednisolone sodium
succinate for injection, USP)

40 mg* per vial

For Intramuscular or Intravenous Use Only

Preservative-Free

Pfizer Injectables
Rx only

PRINCIPAL DISPLAY PANEL - 40 mg Vial Carton

PRINCIPAL DISPLAY PANEL - 40 mg Vial Label - Act-O-Vial System

NDC 0009-0039-33

Rx ONLY

SOLU-MEDROL®
Methylprednisolone Sodium
Succinate for Injection, USP
Single-Dose Vial

For IM or IV Use Only

Discard unused
portion.

40 mg* per vial

Preservative-Free
1 mL Act-O-Vial®
System

novaplus™+

PRINCIPAL DISPLAY PANEL - 40 mg Vial Label - Act-O-Vial System

PRINCIPAL DISPLAY PANEL - 40 mg Vial Carton - Act-O-Vial System

NDC 0009-0039-32
Contains 25 of NDC 0009-0039-33

SOLU-MEDROL®
Methylprednisolone Sodium
Succinate for Injection, USP

40mg* per vial

Preservative-Free

25–1 mL Act-O-Vial®
Systems

For Intramuscular or Intravenous Use Only

Single-Dose Vials

Discard unused portion.

Rx ONLY

novaplus™+

PRINCIPAL DISPLAY PANEL - 40 mg Vial Carton - Act-O-Vial System

PRINCIPAL DISPLAY PANEL - 125 mg Vial Label

NDC 0009-0047-25

2 mL Act-O-Vial®

Solu-Medrol®
(methylprednisolone sodium
succinate for injection, USP)

125 mg* per vial

Preservative-Free
Rx only

PRINCIPAL DISPLAY PANEL - 125 mg Vial Label

PRINCIPAL DISPLAY PANEL - 125 mg Vial Carton

NDC 0009-0047-22
Contains 25 of NDC 0009-0047-25

Single-Dose Vial.
Discard unused portion.
25–2 mL Act-O-Vial® Systems

Solu-Medrol®
(methylprednisolone sodium
succinate for injection, USP)

125 mg* per vial

For Intramuscular or Intravenous Use Only

Preservative-Free

Pfizer Injectables
Rx only

PRINCIPAL DISPLAY PANEL - 125 mg Vial Carton

PRINCIPAL DISPLAY PANEL - 125 mg Vial Label - Act-O-Vial System

NDC 0009-0047-27

Rx ONLY

SOLU-MEDROL®
Methylprednisolone Sodium
Succinate for Injection, USP
Single-Dose Vial

For IM or IV Use Only

Discard unused
portion.

125 mg* per vial

Preservative-Free
2 mL Act-O-Vial®
System

novaplus™+

PRINCIPAL DISPLAY PANEL - 125 mg Vial Label - Act-O-Vial System

PRINCIPAL DISPLAY PANEL - 125 mg Vial Carton - Act-O-Vial System

NDC 0009-0047-26
Contains 25 of NDC 0009-0047-27

SOLU-MEDROL®
Methylprednisolone Sodium
Succinate for Injection, USP

125 mg* per vial

Preservative-Free

25–2 mL Act-O-Vial®
Systems

For Intramuscular or Intravenous Use Only

Single-Dose Vials

Discard unused portion.

Rx ONLY

novaplus™+

PRINCIPAL DISPLAY PANEL - 125 mg Vial Carton - Act-O-Vial System

PRINCIPAL DISPLAY PANEL - 500 mg Vial Label - Act-O-Vial System

Single-Dose Vial.
Discard unused portion.
4 mL Act-O-Vial®

NDC 0009-0003-02

Solu-Medrol®
(methylprednisolone sodium
succinate for injection, USP)

500 mg* per vial

Preservative-Free
Rx only

PRINCIPAL DISPLAY PANEL - 500 mg Vial Label - Act-O-Vial System

PRINCIPAL DISPLAY PANEL - 500 mg Vial Carton - Act-O-Vial System

NDC 0009-0003-02

Single-Dose Vial.
Discard unused portion.
4 mL Act-O-Vial®

Solu-Medrol®
(methylprednisolone
sodium succinate
for injection, USP)

500 mg*
per vial

For Intramuscular or
Intravenous Use Only

Preservative-Free

Rx only

Pfizer Injectables

PRINCIPAL DISPLAY PANEL - 500 mg Vial Carton - Act-O-Vial System

PRINCIPAL DISPLAY PANEL - 1 gram Vial Label - Act-O-Vial System

Single-Dose Vial.
Discard unused portion.
8 mL Act-O-Vial®

NDC 0009-0018-20

Solu-Medrol®
(methylprednisolone sodium
succinate for injection, USP)

1 gram* per vial

Preservative-Free
Rx only

PRINCIPAL DISPLAY PANEL - 1 gram Vial Label - Act-O-Vial System

PRINCIPAL DISPLAY PANEL - 1 gram Vial Carton - Act-O-Vial System

NDC 0009-0018-20

Single-Dose Vial.
Discard unused portion.
8 mL Act-O-Vial®

Solu-Medrol®
(methylprednisolone
sodium succinate
for injection, USP)

1 gram*
per vial

For Intramuscular or
Intravenous Use Only

Preservative-Free

Rx only

Pfizer Injectables

PRINCIPAL DISPLAY PANEL - 1 gram Vial Carton - Act-O-Vial System

PRINCIPAL DISPLAY PANEL - 2 grams Vial Label - 0850

NDC 0009-0850-01

Single-Dose Vial.
Discard unused portion.

Solu-Medrol®
(methylprednisolone sodium
succinate for injection, USP)

2 grams* per vial

This Package Does Not Contain
Diluent.
Recommended Diluent (Bacteriostatic
Water for Injection) Contains Benzyl
Alcohol as a Preservative.

Rx only

PRINCIPAL DISPLAY PANEL - 2 grams Vial Label - 0850

PRINCIPAL DISPLAY PANEL - 2 grams Vial Carton - 0850

NDC 0009-0850-01

1 Vial
Single-Dose Vial.
Discard unused portion.

Solu-Medrol®
(methylprednisolone sodium
succinate for injection, USP)

2 grams* per vial

For Intramuscular or Intravenous Use Only

This Package Does Not Contain Diluent.
The Recommended Diluent (Bacteriostatic Water for Injection)
Contains Benzyl Alcohol as a Preservative.

Pfizer Injectables

Rx only

PRINCIPAL DISPLAY PANEL - 2 grams Vial Carton - 0850

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

SOLU-MEDROL® Quick Finder

Ingredient & Allergen Checker
Pfizer samples (for eligible HCPs)

Requests for samples of prescription medications can be made by contacting Pfizer for Professionals at 1-800-505-4426 or by visiting the PfizerPro website www.pfizerpro.com.
Report an adverse event or concern about the quality of a Pfizer product

To report an adverse event related to Pfizer-BioNTech COVID-19 Vaccine (also known as COMIRNATY®, COVID-19 mRNA, Vaccine BNT162b2 or BNT162) or Pfizer COVID-19 Treatment (also known as PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets)), and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site
*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.
If you cannot use the above website or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
If you prefer, you may contact the U.S. Food and Drug Administration (FDA) directly by visiting www.fda.gov/medwatch or by calling (800)-332-1088.
Assistance programs (for eligible patients)

Pfizer RxPathways connects eligible patients to a range of assistance programs that offer insurance support, co-pay help, and medicines for free or at a savings. Patients and physicians can contact RxPathways at (866) 706-2400 or visit the website for more information on these programs www.pfizerrxpathways.com.
Resources

Show All Hide All

INDICATIONS AND USAGE

When oral therapy is not feasible, and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, the ...

Did you find an answer to your question? Yes No

DOSAGE AND ADMINISTRATION

NOTE: Some of the SOLU-MEDROL formulations contain benzyl alcohol (see DESCRIPTION, WARNINGS and PRECAUTIONS,...

Did you find an answer to your question? Yes No

CONTRAINDICATIONS

SOLU-MEDROL Sterile Powder is contraindicated:

in systemic fungal infections and patients with known hypersensitivity to the product and its constituents. The SOLU-MEDROL 40 mg presentation...

Did you find an answer to your question? Yes No

WARNINGS

Serious Neurologic Adverse Reactions with Epidural Administration

Serious neurologic events, some resulting in death, have been reported with epidural...

Did you find an answer to your question? Yes No

ADVERSE REACTIONS

The following adverse reactions have been reported with SOLU-MEDROL or other corticosteroids:

Allergic reactions: Allergic or hypersensitivity reactions, anaphylactoid...

Did you find an answer to your question? Yes No

OVERDOSAGE

Treatment of acute overdosage is by supportive and symptomatic therapy. For chronic overdosage in the face of severe disease requiring continuous steroid therapy, the dosage of the corticosteroid may be reduced...

Did you find an answer to your question? Yes No

DESCRIPTION

SOLU-MEDROL Sterile Powder is an anti-inflammatory glucocorticoid, which contains methylprednisolone sodium succinate as the active ingredient. Methylprednisolone sodium succinate, USP, is the sodium succinate...

Did you find an answer to your question? Yes No

CLINICAL PHARMACOLOGY

Glucocorticoids, naturally occurring and synthetic, are adrenocortical steroids that are readily absorbed from the gastrointestinal tract.

Naturally occurring glucocorticoids (hydrocortisone and...

Did you find an answer to your question? Yes No

HOW SUPPLIED

SOLU-MEDROL Sterile Powder preserved with benzyl alcohol is available in the following packages:

...

Did you find an answer to your question? Yes No

The formulations containing benzyl alcohol should not be used in neonates.

For Intravenous or Intramuscular Administration...

Did you find an answer to your question? Yes No

Didn’t find what you were looking for? Contact us.

MI Digital Assistant

Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.

Call 800-438-1985^*

*Contact Medical Information. 8AM-9PM ET Monday to Friday; excluding holidays.

Medical Inquiry

Submit a medical question for Pfizer prescription products.

Report Adverse Event

Pfizer Safety

To report an adverse event related to Pfizer-BioNTech COVID-19 Vaccine (also known as COMIRNATY®, COVID-19 mRNA, Vaccine BNT162b2 or BNT162) or Pfizer COVID-19 Treatment (also known as PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets)), and you are not part of a clinical trial* for this product, click the link below to submit your information:

Pfizer Safety Reporting Site

*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.

If you cannot use the above website or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at
(800) 438-1985.

FDA Medwatch

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatchor by calling
(800)-332-1088.

SOLU-MEDROL®Principal Display Panel (methylprednisolone sodium succinate)

PRINCIPAL DISPLAY PANEL - 500 mg Vial Label

PRINCIPAL DISPLAY PANEL - 500 mg Vial Carton

PRINCIPAL DISPLAY PANEL - 1 gram Vial Label

PRINCIPAL DISPLAY PANEL - 1 gram Vial Carton

PRINCIPAL DISPLAY PANEL - 2 gram Vial Label

PRINCIPAL DISPLAY PANEL - 2 gram Vial Carton

PRINCIPAL DISPLAY PANEL - 40 mg Vial Label

PRINCIPAL DISPLAY PANEL - 40 mg Vial Carton

PRINCIPAL DISPLAY PANEL - 40 mg Vial Label - Act-O-Vial System

PRINCIPAL DISPLAY PANEL - 40 mg Vial Carton - Act-O-Vial System

PRINCIPAL DISPLAY PANEL - 125 mg Vial Label

PRINCIPAL DISPLAY PANEL - 125 mg Vial Carton

PRINCIPAL DISPLAY PANEL - 125 mg Vial Label - Act-O-Vial System

PRINCIPAL DISPLAY PANEL - 125 mg Vial Carton - Act-O-Vial System

PRINCIPAL DISPLAY PANEL - 500 mg Vial Label - Act-O-Vial System

PRINCIPAL DISPLAY PANEL - 500 mg Vial Carton - Act-O-Vial System

PRINCIPAL DISPLAY PANEL - 1 gram Vial Label - Act-O-Vial System

PRINCIPAL DISPLAY PANEL - 1 gram Vial Carton - Act-O-Vial System

PRINCIPAL DISPLAY PANEL - 2 grams Vial Label - 0850

PRINCIPAL DISPLAY PANEL - 2 grams Vial Carton - 0850

INDICATIONS AND USAGE

DOSAGE AND ADMINISTRATION

CONTRAINDICATIONS

WARNINGS

Serious Neurologic Adverse Reactions with Epidural Administration

ADVERSE REACTIONS

OVERDOSAGE

DESCRIPTION

CLINICAL PHARMACOLOGY

HOW SUPPLIED

SOLU-MEDROL^®Principal Display Panel (methylprednisolone sodium succinate)